Hjem › Idiopatisk trombocytopenisk purpura › California
Kliniske studier for Idiopatisk trombocytopenisk purpura i California
10 studier for Idiopatisk trombocytopenisk purpura søker deltakere på steder i California.
Byer i California
Offisiell studietekst (engelsk)
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
- USC Norris Comprehensive Cancer Center, Los Angeles
- Stanford University, Palo Alto
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT06721013A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
- University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT06722235A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)
- MemorialCare Long Beach Medical Center, Long Beach
RekruttererFase 3
Alder 18 til 100 · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07700238Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
- Usc Norris Comprehensive Cancer Center, Los Angeles
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT07104565A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
- University of Southern California, Los Angeles
RekruttererFase 3
Alder 18 til 70 · Alle kjønn · Oppdatert 11. sep. 2026 · NCT07059000A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
- University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT06948318OM336 in Autoimmune Cytopenias
- City of Hope, Duarte
RekruttererFase 1
Alder 18 til 75 · Alle kjønn · Oppdatert 3. sep. 2026 · NCT07083960Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- University of California-Irvine, Orange
RekruttererFase 1
Alder 18 til 85 · Alle kjønn · Oppdatert 22. jul. 2026 · NCT06371417Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
- Community Health Partners (CHP) - Community Medical Oncology Specialists (University Oncology Associates), Clovis
- University of Southern California (USC), Los Angeles
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 22. jun. 2026 · NCT07007962A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
- University of Southern California Norris Comprehensive Cancer Center, Los Angeles
- Sharp Memorial Hospital, Oceanside
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 1. mai 2026 · NCT06544499Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.